Total Payments
$832,439
2024 Payments
$108,660
Companies
40
Transactions
769
Medicare Patients
83
Medicare Billing
$3,162
Payment Breakdown by Category
Other$343,167 (41.2%)
Consulting$339,473 (40.8%)
Travel$132,787 (16.0%)
Food & Beverage$14,978 (1.8%)
Education$1,200 (0.1%)
Research$833.06 (0.1%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Consulting Fee | $339,473 | 92 | 40.8% |
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $331,917 | 170 | 39.9% |
| Travel and Lodging | $132,787 | 281 | 16.0% |
| Food and Beverage | $14,978 | 217 | 1.8% |
| Honoraria | $5,200 | 2 | 0.6% |
| Grant | $5,075 | 1 | 0.6% |
| Education | $1,200 | 3 | 0.1% |
| Compensation for serving as faculty or as a speaker for a medical education program | $975.00 | 1 | 0.1% |
| Unspecified | $833.06 | 2 | 0.1% |
Payments by Type
General
$831,606
767 transactions
Research
$833.06
2 transactions
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| E.R. Squibb & Sons, L.L.C. | $213,929 | 112 | $0 (2024) |
| PFIZER INC. | $180,327 | 161 | $0 (2024) |
| Gilead Sciences, Inc. | $97,599 | 106 | $0 (2024) |
| AstraZeneca Pharmaceuticals LP | $71,088 | 70 | $0 (2024) |
| Alexion Pharmaceuticals, Inc. | $50,257 | 72 | $0 (2022) |
| Sunovion Pharmaceuticals Inc. | $38,811 | 80 | $0 (2018) |
| Novartis Pharmaceuticals Corporation | $30,192 | 25 | $0 (2020) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $16,816 | 6 | $0 (2020) |
| Mylan Specialty L.P. | $16,516 | 19 | $0 (2020) |
| Novo Nordisk Inc | $15,812 | 10 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $108,660 | 93 | Gilead Sciences, Inc. ($64,034) |
| 2023 | $66,806 | 79 | Gilead Sciences, Inc. ($30,765) |
| 2022 | $12,665 | 16 | Alexion Pharmaceuticals, Inc. ($3,872) |
| 2021 | $43,553 | 39 | AstraZeneca Pharmaceuticals LP ($25,500) |
| 2020 | $50,833 | 31 | PFIZER INC. ($10,089) |
| 2019 | $126,641 | 124 | PFIZER INTERNATIONAL LLC ($54,841) |
| 2018 | $223,899 | 172 | E.R. Squibb & Sons, L.L.C. ($117,814) |
| 2017 | $199,382 | 215 | E.R. Squibb & Sons, L.L.C. ($92,315) |
All Payment Transactions
769 individual payment records from CMS Open Payments — Page 1 of 31
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/20/2024 | Gilead Sciences, Inc. | Veklury (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $2,060.00 | General |
| Category: COVID-19 | ||||||
| 12/19/2024 | Gilead Sciences, Inc. | Veklury (Drug) | Consulting Fee | Cash or cash equivalent | $4,520.00 | General |
| Category: COVID-19 | ||||||
| 12/19/2024 | Gilead Sciences, Inc. | Veklury (Drug) | Food and Beverage | In-kind items and services | $39.58 | General |
| Category: COVID-19 | ||||||
| 12/19/2024 | Gilead Sciences, Inc. | Veklury (Drug) | Travel and Lodging | In-kind items and services | $33.50 | General |
| Category: COVID-19 | ||||||
| 12/19/2024 | Gilead Sciences, Inc. | Veklury (Drug) | Travel and Lodging | In-kind items and services | $33.50 | General |
| Category: COVID-19 | ||||||
| 12/19/2024 | Gilead Sciences, Inc. | Veklury (Drug) | Food and Beverage | In-kind items and services | $30.77 | General |
| Category: COVID-19 | ||||||
| 12/19/2024 | Gilead Sciences, Inc. | Veklury (Drug) | Food and Beverage | In-kind items and services | $25.21 | General |
| Category: COVID-19 | ||||||
| 12/19/2024 | Gilead Sciences, Inc. | Veklury (Drug) | Food and Beverage | In-kind items and services | $16.70 | General |
| Category: COVID-19 | ||||||
| 12/19/2024 | Gilead Sciences, Inc. | Veklury (Drug) | Food and Beverage | In-kind items and services | $16.70 | General |
| Category: COVID-19 | ||||||
| 12/18/2024 | Gilead Sciences, Inc. | Veklury (Drug) | Consulting Fee | Cash or cash equivalent | $4,520.00 | General |
| Category: COVID-19 | ||||||
| 12/06/2024 | Gilead Sciences, Inc. | Veklury (Drug) | Food and Beverage | In-kind items and services | $39.58 | General |
| Category: COVID-19 | ||||||
| 12/06/2024 | Gilead Sciences, Inc. | Veklury (Drug) | Food and Beverage | In-kind items and services | $30.77 | General |
| Category: COVID-19 | ||||||
| 12/06/2024 | Gilead Sciences, Inc. | Veklury (Drug) | Food and Beverage | In-kind items and services | $25.21 | General |
| Category: COVID-19 | ||||||
| 11/21/2024 | Gilead Sciences, Inc. | Veklury (Drug) | Consulting Fee | Cash or cash equivalent | $2,850.00 | General |
| Category: COVID-19 | ||||||
| 11/21/2024 | Gilead Sciences, Inc. | Veklury (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $413.33 | General |
| Category: COVID-19 | ||||||
| 11/19/2024 | Gilead Sciences, Inc. | Veklury (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $2,670.00 | General |
| Category: COVID-19 | ||||||
| 11/06/2024 | Gilead Sciences, Inc. | Veklury (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $2,060.00 | General |
| Category: COVID-19 | ||||||
| 10/18/2024 | Invivyd Inc | PEMGARDA (Biological) | Food and Beverage | In-kind items and services | $30.04 | General |
| Category: INFECTIOUS DISEASE | ||||||
| 10/11/2024 | Invivyd Inc | PEMGARDA (Biological) | Consulting Fee | Cash or cash equivalent | $1,750.00 | General |
| Category: INFECTIOUS DISEASE | ||||||
| 08/19/2024 | Novo Nordisk AS | — | Consulting Fee | Cash or cash equivalent | $562.50 | General |
| 08/08/2024 | ABBVIE INC. | TEFLARO (Drug) | Consulting Fee | Cash or cash equivalent | $825.00 | General |
| Category: ANTI-INFECTIVE | ||||||
| 08/07/2024 | AIMMUNE THERAPEUTICS, INC. | VOWST (Biological) | Food and Beverage | In-kind items and services | $56.22 | General |
| Category: GI | ||||||
| 07/15/2024 | Bayer Healthcare Pharmaceuticals Inc. | — | Consulting Fee | Cash or cash equivalent | $7,380.00 | General |
| 07/15/2024 | Bayer Healthcare Pharmaceuticals Inc. | — | Travel and Lodging | In-kind items and services | $1,158.64 | General |
| 07/15/2024 | Bayer Healthcare Pharmaceuticals Inc. | — | Travel and Lodging | In-kind items and services | $230.00 | General |
Research Studies & Clinical Trials
| Study Name | Company | Amount | Records |
|---|---|---|---|
| Elevated Heart Rate and Rehospitalization: A Retrospective Medical Record Review of Patients with S | Amgen Inc. | $833.06 | 2 |
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 1 | 11 | 11 | $5,203 | $1,088 |
| 2022 | 1 | 13 | 24 | $1,776 | $91.51 |
| 2021 | 1 | 37 | 171 | $12,654 | $1,265 |
| 2020 | 1 | 22 | 89 | $6,480 | $717.18 |
Total Patients
83
Total Services
295
Medicare Billing
$3,162
Procedure Codes
4
All Medicare Procedures & Services
4 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99239 | Hospital discharge day management, more than 30 minutes | Facility | 2023 | 11 | 11 | $5,203 | $1,088 | 20.9% |
| 99211 | Office or other outpatient visit for the evaluation and management of established patient that may not require presence of healthcare professional | Facility | 2022 | 13 | 24 | $1,776 | $91.51 | 5.2% |
| 99211 | Established patient outpatient visit, minimal presenting problem | Facility | 2021 | 37 | 171 | $12,654 | $1,265 | 10.0% |
| 99211 | Established patient office or other outpatient visit, typically 5 minutes | Facility | 2020 | 22 | 89 | $6,480 | $717.18 | 11.1% |
About Dr. Alpesh Amin, MD
Dr. Alpesh Amin, MD is a Family Medicine healthcare provider based in Orange, California. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 06/14/2006. The National Provider Identifier (NPI) number assigned to this provider is 1457394801.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Alpesh Amin, MD has received a total of $832,439 in payments from pharmaceutical and medical device companies, with $108,660 received in 2024. These payments were reported across 769 transactions from 40 companies. The most common payment nature is "Consulting Fee" ($339,473).
As a Medicare-enrolled provider, Amin has provided services to 83 Medicare beneficiaries, totaling 295 services with total Medicare billing of $3,162. Data is available for 4 years (2020–2023), covering 4 distinct procedure/service records.
Ad
Practice Information
- Specialty Family Medicine
- Other Specialties Internal Medicine, Hospitalist
- Location Orange, CA
- Active Since 06/14/2006
- Last Updated 06/25/2025
- Taxonomy Code 207Q00000X
- Entity Type Individual
- NPI Number 1457394801
Products in Payments
- ELIQUIS (Drug) $315,784
- Veklury (Drug) $95,759
- LOKELMA (Drug) $60,901
- UTIBRON (Drug) $32,433
- XIFAXAN (Drug) $18,010
- SAMSCA (Drug) $14,737
- ENTRESTO (Drug) $14,311
- PAXLOVID (Drug) $13,007
- Yupelri (Drug) $12,374
- Ultomiris (Drug) $11,817
- BEVYXXA (Drug) $8,287
- STIOLTO RESPIMAT (Drug) $7,968
- PRAXBIND (Drug) $7,075
- OXBRYTA (Drug) $6,823
- SERELAXIN (Drug) $6,673
- SOLIQUA (Drug) $6,487
- NUZYRA (Drug) $6,409
- SOLIRIS (Drug) $5,506
- LONHALA MAGNAIR (Drug) $4,953
- Corlanor (Drug) $4,208
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Family Medicine Doctors in Orange
Desiree A Lie, Md, MD
Family Medicine — Payments: $64,035
Family Medicine $64,035
Francis Gialanella, Md, MD
Family Medicine — Payments: $37,205
Family Medicine $37,205
Dr. Anjani Kolahi, Md, MD
Family Medicine — Payments: $28,060
Family Medicine $28,060
Giuseppe Salese, Md, MD
Family Medicine — Payments: $18,305
Family Medicine $18,305
David Kritz, Md, MD
Family Medicine — Payments: $15,669
Family Medicine $15,669
Dr. Calvin Parker, Md, MD
Family Medicine — Payments: $14,512
Family Medicine $14,512